Search results
Contraline’s male contraceptive device trial gets sperm analysis collab
Clinical Trials Arena via Yahoo Finance· 23 hours agoDNA Diagnostics Centre (DDC) will supply a home test kit for sperm detection to Contraline’s...
More Women in Africa Are Using Long-Acting Contraception, Changing Lives
New York Times· 5 days agoMethods such as hormonal implants and injections are reaching remote areas, providing more...
The Supreme Court Overruled Roe Two Years Ago, Ending Right To Abortion. Birth Control May Be Next.
Forbes· 1 day agoJustice Clarence Thomas laid out that, in the future, the court should reconsider other rulings that relied on the same principles as Roe – including Griswold v. Connecticut, the Court’s 1965 ...
Women’s health: How innovations in implantable drug delivery systems are improving lives
Medical Device Network via Yahoo Finance· 4 days agoImplantable devices are a highly effective method of drug delivery for women’s health applications....
Struggling with ‘bacne?’ New treatments can help an embarrassing problem.
Washington Post· 1 day agoBacne, the colloquial term for back acne, is a common and stubborn condition that has been shown to...
Tuesday Briefing
New York Times· 4 days agoIsrael’s prime minister dissolved his war cabinet.
Tuesday Briefing: Netanyahu Disbands His War Cabinet
New York Times· 5 days agoAlso, President Vladimir Putin’s state visit to North Korea.
Polycystic Ovarian Syndrome: New Science Offers Old Remedy
Medscape· 4 days agoAn ancient Chinese remedy for malaria could offer new hope to the 10% of reproductive-age women...
Opinion: Call it ‘Make America Chaste Again.’ And it’s a losing message for the GOP in 2024
CNN via Yahoo News· 4 days agoIn Arizona, GOP Senate Majority Leader Sonny Borrelli absurdly suggested that women could simply...
Agile Therapeutics (NASDAQ:AGRX) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report report published on Saturday. The firm issued a sell rating on the specialty pharmaceutical ...